Related Experiment Video
Updated: May 4, 2026

06:09
An In Ovo Model for Testing Insulin-mimetic Compounds
Published on: April 23, 2018
11.5K
Polyherbal preparation for anti-diabetic activity: a screening study
Noopur Srivastava1, Gaurav Tiwari, Ruchi Tiwari
1Department of Pharmaceutical Sciences, Bhagwant University, Sikar Road, Ajmer, India.
Indian Journal of Medical Sciences
|June 22, 2012
Summary
This study screened a polyherbal preparation for anti-diabetic activity. The preparation significantly lowered blood glucose in normal and diabetic rats, showing promise for diabetes management.
Area of Science:
- Pharmacology
- Natural Product Chemistry
- Diabetology
Background:
- Diabetes mellitus is a global health concern requiring effective and accessible treatments.
- Polyherbal preparations, combining multiple medicinal plants, offer potential synergistic therapeutic effects.
- Wheat germ oil, Coriandrum sativum, and Aloe vera are traditional remedies with purported health benefits.
Purpose of the Study:
- To evaluate the anti-diabetic efficacy of a novel polyherbal preparation in a rat model.
- To screen the blood glucose-lowering activity of different formulations of the polyherbal preparation.
- To assess the safety and efficacy of the preparation in both normal and alloxan-induced diabetic rats.
Main Methods:
- Three polyherbal preparations (I, II, III) with varying ratios of Wheat germ oil, Coriandrum sativum, and Aloe vera were formulated.
- Blood glucose levels were measured in normal rats and alloxan-induced diabetic rats following oral administration of the preparations.
- Glucose levels were monitored over specific time intervals using the GOD/POD method and analyzed statistically.
Main Results:
- Polyherbal preparation-I demonstrated a significant reduction in blood glucose levels in normal rats.
- All three polyherbal preparations (I, II, and III) significantly reduced blood glucose levels in diabetic rats over a 30-day study period.
- The observed reductions were statistically significant when compared to control groups and the standard anti-diabetic drug, Glibenclamide.
Conclusions:
- The polyherbal preparation exhibits significant anti-diabetic properties, effectively lowering blood glucose in both normal and diabetic conditions.
- The findings suggest that this polyherbal preparation is a promising candidate for the development of affordable anti-diabetic treatments for the general population.
- Further extensive clinical studies in humans are warranted to confirm the efficacy and safety of this preparation for widespread use.
More Related Videos
Related Concept Videos
Oral Hypoglycemic Agents: Biguanides and Glitazones
993
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
993
Oral Hypoglycemic Agents: Glinides
1.0K
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
1.0K
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
953
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
953
Dipeptidyl Peptidase 4 Inhibitors
1.1K
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
1.1K

